JASON FALCONE: Open Payments
NPI 1487615571 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 36 payments from 18 companies in 2025. Trend: 2023 $1,571 · 2024 $967 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $108 |
| Ferring Pharmaceuticals Inc. | 6 | $104 |
| Procept Biorobotics Corporation | 1 | $92 |
| Dendreon Pharmaceuticals LLC | 4 | $85 |
| Antares Pharma, Inc. | 3 | $64 |
| Medtronic, Inc. | 2 | $52 |
| DENTSPLY IH AB | 1 | $49 |
| IMMUNITYBIO, INC. | 3 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| ABBVIE INC. | 1 | $28 |
Products named: ERLEADA, ADSTILADRIN, AQUABEAM ROBOTIC SYSTEM, PROVENGE, XYOSTED, LOFRIC, ANKTIVA, ORGOVYX.
Industry payments across NY — which companies pay providers there.
